Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma.

Affiliation

Bakouny Z(1), Braun DA(1), Shukla SA(2), Pan W(1), Gao X(3), Hou Y(2), Flaifel A(4), Tang S(1), Bosma-Moody A(1), He MX(1), Vokes N(1), Nyman J(1), Xie W(5), Nassar AH(1), Abou Alaiwi S(1), Flippot R(1), Bouchard G(1), Steinharter JA(1), Nuzzo PV(1), Ficial M(4), Sant'Angelo M(4), Forman J(1)(2)(6), Berchuck JE(1), Dudani S(7), Bi K(1), Park J(1), Camp S(1), Sticco-Ivins M(4), Hirsch L(1), Baca SC(1), Wind-Rotolo M(8), Ross-Macdonald P(8), Sun M(1), Lee GM(1), Chang SL(1), Wei XX(1), McGregor BA(1), Harshman LC(1), Genovese G(9), Ellis L(4)(10), Pomerantz M(1), Hirsch MS(4), Freedman ML(1), Atkins MB(11), Wu CJ(1)(6), Ho TH(12), Linehan WM(13), McDermott DF(14), Heng DYC(7), Viswanathan SR(1), Signoretti S(4)(10), Van Allen EM(#)(15), Choueiri TK(#)(16).
Author information:
(1)Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
(2)Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.
(3)Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
(4)Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
(5)Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.
(6)Broad Institute of MIT and Harvard, Cambridge, MA, USA.
(7)Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada.
(8)Bristol-Myers Squibb, Princeton, NJ, USA.
(9)Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
(10)Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.
(11)Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
(12)Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA.
(13)Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
(14)Beth Israel Deaconess Medical Center, Boston, MA, USA.
(15)Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. [Email]
(16)Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. [Email]
(#)Contributed equally

Abstract

Comment in Nat Rev Urol. 2021 Apr;18(4):189.